Enanta Pharmaceuticals: From Failure To Formidable

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

IMAGINE YOU WERE APPROACHED BY A RECRUITER WITH THE FOLLOWING PITCH:

CEO wanted for life sciences company that recently experienced significant failure. Provisos? Company currently has no investable assets. You won’t be able to raise any additional money, as the investors on the board want to avoid dilution. Chances of going public reside somewhere between slim and none.

And oh, by the way, your first order of business will be to lay off two-thirds of the company.